434P CodeBreaK 101 subprotocol H: Phase Ib study evaluating combination of sotorasib (Soto), a KRASG12C inhibitor, and panitumumab (PMab), an EGFR inhibitor, in advanced KRAS p.G12C-mutated colorectal cancer (CRC)
Conference Paper
Full Text
Duke Authors
Cited Authors
- Fakih, M; Falchook, GS; Hong, DS; Yaeger, RD; Chan, E; Mather, O; Cardona, P; Dai, T; Strickler, J
Published Date
- September 2021
Published In
Volume / Issue
- 32 /
Start / End Page
- S551 - S551
Published By
International Standard Serial Number (ISSN)
- 0923-7534
Digital Object Identifier (DOI)
- 10.1016/j.annonc.2021.08.955